2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee

Partnering Events:

TechConnect Summit
Clean Technology 2008

Nanotechnology: A Key Enabler of Personalized Medicine

Linda K. Molnar

Linda K. Molnar

Program Officer
Office of Technology and Industrial Relations
National Cancer Institute

Dr. Linda Molnar currently serves as a Program Officer in the Office of Technology and Industrial Relations (OTIR) in the Office of the Director at the National Cancer Institute (NCI). In her role, she supports the management of grants and contracts for nanotechnology applications in cancer research for the NCI Alliance in Cancer Nanotechnology. She has a breadth of experience in collaborations and partnerships between academic institutions, large companies and biotechnology start-ups for the successful translation of fundamental research into applications and products. At NCI, she was instrumental in the successful launch of the Alliance in 2005. She has also led the formation of a clinical translation working group comprised of extramural investigators from the Alliance as well as internal NCI experts organized to address gaps in the clinical translation of nanotechnologies.

Her background includes the research and development of nanotechnology in a variety of applications and employments including Rohm and Haas Company, Caliper Technologies, and the NASA Ames Research Center. She received her Ph.D. in Materials Science and Engineering from the Massachusetts Institute of Technology and her B.S. in Chemistry with Honors from the University of Pittsburgh (magna cum laude). Dr. Molnar has also completed the Wharton Executive Management Program. She is frequently invited to speak on a range of topics in nanotechnology and nanomedicine from both a technical and a business perspective.

Speaking in the special symposium on Nanotechnology for Cancer Prevention, Diagnosis and Treatment.

View Confimed Speakers

← Back to Conferences & Symposia